A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
Stanford Medicine will be the first to use a new technology that aims to heighten precision of radiation therapy in cancer patients.
In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.
A study links ulcerative colitis to the depletion of important acids ordinarily produced by a set of gut microbes mysteriously missing in action.
At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.
A new Stanford study in children with autism showed the value of teaching parents how to use everyday interactions to motivate their children to speak.
A therapy delayed the onset of Type 1 diabetes in at-risk people by about two years, new results from a clinical trial show.
Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
An antibody against the "don't eat me" signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
A Stanford physician argues pregnant women should be appropriately included in clinical research to improve their health and the health of their fetuses.
A study confirmed that patients with peripheral artery disease have a higher risk of heart attack, and are more likely to have a rarer type of heart attack.
Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.
A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.
The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds
A new Stanford-led study catalogs the prevalence and types of deception by volunteers in clinical trials and suggests ways for investigators to root it out.